Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.5648003732746604e-61,79.79751961528727,11133.015587050875,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.847744851066225e-59,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.701500173012807e-25,17.410350843186663,992.9665767934492,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.9397101972346e-23,0,0,40
3,Nonalcoholic fatty liver disease WP4396,9.090239072056046e-16,9.107426465917031,315.42806795437605,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS', 'BAX']",6.908581694762595e-14,0,0,32
4,Mitochondrial CIV Assembly WP4922,3.075244399930858e-11,22.808704453441294,552.0858692552404,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",1.752889307960589e-09,0,0,15
5,Oxidative phosphorylation WP623,2.687350537433446e-09,8.67102583342266,171.1201807368459,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.2254318450696515e-07,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.2716137955135378e-08,9.121703853955376,165.83616951467556,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",4.832132422951443e-07,0,0,16
7,Mitochondrial complex III assembly WP4921,7.7259090108353e-07,62.91633466135458,885.4540528231014,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",2.5164389349577832e-05,0,0,7
8,Cellular Proteostasis WP4918,5.776627321230754e-05,44.76190476190476,436.8361492080466,"['VBP1', 'PFDN1', 'PFDN4', 'PFDN5', 'PFDN6']",0.0016463387865507649,0,0,5
9,Pyrimidine metabolism WP4022,0.0023343064902200165,3.458455372283028,20.958379410112293,"['NT5C', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.05913576441890708,0,0,10
10,Proteasome Degradation WP183,0.003454734669789148,4.481075697211155,25.398780162969192,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10']",0.0718953647861894,0,0,7
11,mRNA Processing WP411,0.003468636020386331,5.371371769383698,30.423416614123706,"['LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SRSF9', 'LSM2']",0.0718953647861894,0,0,6
12,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.010254399211387539,inf,inf,"['ELOB', 'ELOC']",0.19483358501636322,0,0,2
13,Dual hijack model of Vif in HIV infection WP3300,0.05355466400557011,8.897435897435898,26.043261004949017,"['ELOB', 'ELOC']",0.939266414866922,0,0,2
14,Eukaryotic Transcription Initiation WP405,0.07235135740016961,3.816487859966121,10.02294081026156,"['POLR2I', 'POLR2J', 'POLR2K']",0.9975414449449176,0,0,3
15,Base Excision Repair WP4752,0.09225549415818182,3.3386857707509883,7.956734028960457,"['POLD4', 'APEX1', 'POLE3']",0.9975414449449176,0,0,3
16,Insulin signaling in adipocytes (diabetic condition) WP3635,0.10135378896323277,inf,inf,['RPS6'],0.9975414449449176,0,0,1
17,Insulin signaling in adipocytes (normal condition) WP3634,0.10135378896323277,inf,inf,['RPS6'],0.9975414449449176,0,0,1
18,Mitochondrial CII Assembly WP4920,0.10135378896323277,inf,inf,['SDHAF1'],0.9975414449449176,0,0,1
19,Nucleotide Excision Repair WP4753,0.11412626289055038,2.9670619235836626,6.439859179006989,"['POLD4', 'POLE3', 'GTF2H5']",0.9975414449449176,0,0,3
20,DNA Repair Pathways Full Network WP4946,0.11622320147573179,2.122071050642479,4.5672121101874685,"['POLD4', 'CENPX', 'APEX1', 'POLE3', 'GTF2H5']",0.9975414449449176,0,0,5
21,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.11684221349436792,4.446745562130178,9.546855260474075,"['EIF3D', 'EIF1']",0.9975414449449176,0,0,2
22,VEGFA-VEGFR2 Signaling Pathway WP3888,0.14795765835024433,1.370284919065407,2.6183803512305155,"['SET', 'RPS6', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9975414449449176,0,0,17
23,Selenium Micronutrient Network WP15,0.15144352187662824,1.7825049701789264,3.364553916961941,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOH']",0.9975414449449176,0,0,6
24,Gastric Cancer Network 2 WP2363,0.15296455895967437,3.5566074950690334,6.677704935417938,"['S100A6', 'COL9A3']",0.9975414449449176,0,0,2
25,Non-small cell lung cancer WP4255,0.1890781271281194,2.2238142292490117,3.703973812883705,"['CYCS', 'BAX', 'HRAS']",0.9975414449449176,0,0,3
26,Serotonin and anxiety WP3947,0.19084681060465616,2.963182117028271,4.907871756113703,"['POMC', 'CRH']",0.9975414449449176,0,0,2
27,MED and Pseudoachondroplasia genes WP4789,0.19245322821080313,8.881889763779528,14.636485016723814,['COL9A3'],0.9975414449449176,0,0,1
28,Peroxiredoxin 2 induced ovarian failure WP4873,0.19245322821080313,8.881889763779528,14.636485016723814,['BAX'],0.9975414449449176,0,0,1
29,Purine metabolism WP4792,0.19245322821080313,8.881889763779528,14.636485016723814,['APRT'],0.9975414449449176,0,0,1
30,Translation Factors WP107,0.21634749777502577,2.0522955305564,3.1417963823604955,"['EEF1B2', 'EIF3D', 'EIF1']",0.9975414449449176,0,0,3
31,TP53 network WP1742,0.22976306329674667,2.5393068469991547,3.734575493232967,"['SUMO1', 'BAX']",0.9975414449449176,0,0,2
32,DNA Mismatch Repair WP531,0.22976306329674667,2.5393068469991547,3.734575493232967,"['POLD4', 'POLE3']",0.9975414449449176,0,0,2
33,Ciliary landscape WP4352,0.23926180392431215,1.44955063467062,2.0731428424638985,"['COPS6', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'COX6C', 'LSM4']",0.9975414449449176,0,0,7
34,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.2436206978057616,1.6942951438000944,2.392586655173783,"['POMC', 'RPS6', 'ZNF516', 'HRAS']",0.9975414449449176,0,0,4
35,Glycosylation and related congenital defects WP4521,0.26911599167217004,2.2214003944773175,2.9158385839658902,"['DPM2', 'DPM3']",0.9975414449449176,0,0,2
36,MET in type 1 papillary renal cell carcinoma WP4205,0.26911599167217004,2.2214003944773175,2.9158385839658902,"['RPL11', 'HRAS']",0.9975414449449176,0,0,2
37,Nanomaterial induced apoptosis WP2507,0.26911599167217004,2.2214003944773175,2.9158385839658902,"['BAX', 'CYCS']",0.9975414449449176,0,0,2
38,Endometrial cancer WP4155,0.2729026670599914,1.7778656126482213,2.308807538390082,"['BAX', 'FGF1', 'HRAS']",0.9975414449449176,0,0,3
39,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.2743338611881316,4.43996062992126,5.7426870045711595,['IDH3B'],0.9975414449449176,0,0,1
40,Iron metabolism in placenta WP2007,0.2743338611881316,4.43996062992126,5.7426870045711595,['FTH1'],0.9975414449449176,0,0,1
41,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3017637792473471,1.6663784584980237,1.9965059540242056,"['APEX1', 'RPS6', 'HRAS']",0.9975414449449176,0,0,3
42,Leptin signaling pathway WP2034,0.3017637792473471,1.6663784584980237,1.9965059540242056,"['RPS6', 'BAX', 'HRAS']",0.9975414449449176,0,0,3
43,Modulators of TCR signaling and T cell activation WP5072,0.3017637792473471,1.6663784584980237,1.9965059540242056,"['NDUFB10', 'ELOB', 'RNF7']",0.9975414449449176,0,0,3
44,Interleukin-11 Signaling Pathway WP2332,0.3084183218481504,1.9741398202936664,2.3221771757772647,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
45,IL-18 signaling pathway WP4754,0.3306001915427096,1.218876108381146,1.349107552947146,"['NRN1', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'BPGM', 'RPS11', 'RND2', 'ABCF1']",0.9975414449449176,0,0,10
46,Type 2 papillary renal cell carcinoma WP4241,0.3472767272870826,1.7763313609467455,1.8787072558015352,"['ELOB', 'ELOC']",0.9975414449449176,0,0,2
47,Copper homeostasis WP3286,0.3472767272870826,1.7763313609467455,1.8787072558015352,"['COX17', 'ATOX1']",0.9975414449449176,0,0,2
48,IL-2 signaling pathway WP49,0.3472767272870826,1.7763313609467455,1.8787072558015352,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
49,Parkinson's disease pathway WP2371,0.3472767272870826,1.7763313609467455,1.8787072558015352,"['CYCS', 'PARK7']",0.9975414449449176,0,0,2
50,Serotonin and anxiety-related events WP3944,0.34792691780700674,2.959317585301837,3.1243375015174815,['CRH'],0.9975414449449176,0,0,1
51,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.34792691780700674,2.959317585301837,3.1243375015174815,['DLL3'],0.9975414449449176,0,0,1
52,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.34792691780700674,2.959317585301837,3.1243375015174815,['COX8A'],0.9975414449449176,0,0,1
53,Glutathione metabolism WP100,0.34792691780700674,2.959317585301837,3.1243375015174815,['GPX4'],0.9975414449449176,0,0,1
54,Homologous recombination WP186,0.34792691780700674,2.959317585301837,3.1243375015174815,['POLD4'],0.9975414449449176,0,0,1
55,MTHFR deficiency WP4288,0.34792691780700674,2.959317585301837,3.1243375015174815,['CYCS'],0.9975414449449176,0,0,1
56,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.41406973948573494,2.218996062992126,1.9565351313756152,['HRAS'],0.9975414449449176,0,0,1
57,Cancer immunotherapy by CTLA4 blockade WP4582,0.41406973948573494,2.218996062992126,1.9565351313756152,['HLA-DRB1'],0.9975414449449176,0,0,1
58,Type II diabetes mellitus WP1584,0.41406973948573494,2.218996062992126,1.9565351313756152,['SURF1'],0.9975414449449176,0,0,1
59,Fatty acid transporters WP5061,0.41406973948573494,2.218996062992126,1.9565351313756152,['FABP6'],0.9975414449449176,0,0,1
60,Genes targeted by miRNAs in adipocytes WP1992,0.41406973948573494,2.218996062992126,1.9565351313756152,['TMSB4X'],0.9975414449449176,0,0,1
61,"GPCRs, Class B Secretin-like WP334",0.41406973948573494,2.218996062992126,1.9565351313756152,['ADGRL2'],0.9975414449449176,0,0,1
62,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.41406973948573494,2.218996062992126,1.9565351313756152,['HRAS'],0.9975414449449176,0,0,1
63,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.41406973948573494,2.218996062992126,1.9565351313756152,['VEGFB'],0.9975414449449176,0,0,1
64,Purine metabolism and related disorders WP4224,0.41406973948573494,2.218996062992126,1.9565351313756152,['APRT'],0.9975414449449176,0,0,1
65,RalA downstream regulated genes WP2290,0.41406973948573494,2.218996062992126,1.9565351313756152,['HRAS'],0.9975414449449176,0,0,1
66,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4169222890063211,1.3319169960474309,1.1652348187641044,"['RPS6', 'BAX', 'HRAS']",0.9975414449449176,0,0,3
67,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4449189579932664,1.2682100508187464,1.027076561596265,"['PSMC5', 'PSMD7', 'PSMC1']",0.9975414449449176,0,0,3
68,Kit receptor signaling pathway WP304,0.45838355315252766,1.3654984069185252,1.0651556573109415,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
69,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.45838355315252766,1.3654984069185252,1.0651556573109415,"['NDUFA13', 'COPS6']",0.9975414449449176,0,0,2
70,Thermogenesis WP4321,0.4723687091627863,1.2102946460653972,0.9077154593911967,"['RPS6', 'ZNF516', 'HRAS']",0.9975414449449176,0,0,3
71,Apoptosis Modulation by HSP70 WP384,0.473515218534703,1.7748031496062993,1.3267917670911455,['CYCS'],0.9975414449449176,0,0,1
72,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.473515218534703,1.7748031496062993,1.3267917670911455,['BAX'],0.9975414449449176,0,0,1
73,miR-509-3p alteration of YAP1/ECM axis WP3967,0.473515218534703,1.7748031496062993,1.3267917670911455,['SPARC'],0.9975414449449176,0,0,1
74,miRNA regulation of p53 pathway in prostate cancer WP3982,0.473515218534703,1.7748031496062993,1.3267917670911455,['BAX'],0.9975414449449176,0,0,1
75,Nanoparticle-mediated activation of receptor signaling WP2643,0.473515218534703,1.7748031496062993,1.3267917670911455,['HRAS'],0.9975414449449176,0,0,1
76,Nucleotide metabolism WP404,0.473515218534703,1.7748031496062993,1.3267917670911455,['NME2'],0.9975414449449176,0,0,1
77,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.473515218534703,1.7748031496062993,1.3267917670911455,['ANAPC11'],0.9975414449449176,0,0,1
78,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4929601160923158,1.2676810369118061,0.8966650357400241,"['IFI27L2', 'HRAS']",0.9975414449449176,0,0,2
79,Androgen receptor signaling pathway WP138,0.49918410910298483,1.1574153634645128,0.8041493878505741,"['SUMO1', 'BAG1', 'PARK7']",0.9975414449449176,0,0,3
80,Cytosolic DNA-sensing pathway WP4655,0.5261064630614122,1.182905982905983,0.7597233612707924,"['POLR2K', 'POLR2L']",0.9975414449449176,0,0,2
81,Ferroptosis WP4313,0.5261064630614122,1.182905982905983,0.7597233612707924,"['GPX4', 'FTH1']",0.9975414449449176,0,0,2
82,BDNF-TrkB Signaling WP3676,0.5269402985672438,1.4786745406824147,0.9473394936179768,['HRAS'],0.9975414449449176,0,0,1
83,Cytokines and Inflammatory Response WP530,0.5269402985672438,1.4786745406824147,0.9473394936179768,['HLA-DRB1'],0.9975414449449176,0,0,1
84,ERK Pathway in Huntington's Disease WP3853,0.5269402985672438,1.4786745406824147,0.9473394936179768,['HRAS'],0.9975414449449176,0,0,1
85,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5269402985672438,1.4786745406824147,0.9473394936179768,['H2AFZ'],0.9975414449449176,0,0,1
86,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5269402985672438,1.4786745406824147,0.9473394936179768,['RPS6'],0.9975414449449176,0,0,1
87,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5269402985672438,1.4786745406824147,0.9473394936179768,['RPS6'],0.9975414449449176,0,0,1
88,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5269402985672438,1.4786745406824147,0.9473394936179768,['SUPT4H1'],0.9975414449449176,0,0,1
89,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5269402985672438,1.4786745406824147,0.9473394936179768,['BAX'],0.9975414449449176,0,0,1
90,Methionine De Novo and Salvage Pathway WP3580,0.5269402985672438,1.4786745406824147,0.9473394936179768,['TXN'],0.9975414449449176,0,0,1
91,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.5269402985672438,1.4786745406824147,0.9473394936179768,['HLA-DRB1'],0.9975414449449176,0,0,1
92,PDGFR-beta pathway WP3972,0.5269402985672438,1.4786745406824147,0.9473394936179768,['HRAS'],0.9975414449449176,0,0,1
93,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5269402985672438,1.4786745406824147,0.9473394936179768,['BAX'],0.9975414449449176,0,0,1
94,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5269402985672438,1.4786745406824147,0.9473394936179768,['HRAS'],0.9975414449449176,0,0,1
95,22q11.2 copy number variation syndrome WP4657,0.5506319981620245,1.0643478260869565,0.6350841854001255,"['RANBP1', 'MRPL40', 'EMC10']",0.9975414449449176,0,0,3
96,Sleep regulation WP3591,0.5577569180124081,1.1087278106508875,0.647310822066658,"['CRH', 'HCRTR1']",0.9975414449449176,0,0,2
97,Biomarkers for pyrimidine metabolism disorders WP4584,0.5749536216233077,1.267154105736783,0.7013265869167604,['NT5C'],0.9975414449449176,0,0,1
98,Cancer immunotherapy by PD-1 blockade WP4585,0.5749536216233077,1.267154105736783,0.7013265869167604,['HLA-DRB1'],0.9975414449449176,0,0,1
99,MAPK Cascade WP422,0.5749536216233077,1.267154105736783,0.7013265869167604,['HRAS'],0.9975414449449176,0,0,1
100,NOTCH1 regulation of endothelial cell calcification WP3413,0.5749536216233077,1.267154105736783,0.7013265869167604,['DLL3'],0.9975414449449176,0,0,1
101,Overview of nanoparticle effects WP3287,0.5749536216233077,1.267154105736783,0.7013265869167604,['BAX'],0.9975414449449176,0,0,1
102,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5749536216233077,1.267154105736783,0.7013265869167604,['HRAS'],0.9975414449449176,0,0,1
103,Pyrimidine metabolism and related diseases WP4225,0.5749536216233077,1.267154105736783,0.7013265869167604,['NT5C'],0.9975414449449176,0,0,1
104,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5749536216233077,1.267154105736783,0.7013265869167604,['BAX'],0.9975414449449176,0,0,1
105,TNF-alpha signaling pathway WP231,0.5751563255436054,1.0231833384007296,0.5659364198576428,"['BAX', 'TXN', 'HRAS']",0.9975414449449176,0,0,3
106,Genotoxicity pathway WP4286,0.5878737370848975,1.0432764821905094,0.5542334189837083,"['RPS27', 'TRIAP1']",0.9975414449449176,0,0,2
107,p53 transcriptional gene network WP4963,0.5878737370848975,1.0432764821905094,0.5542334189837083,"['SIVA1', 'BAX']",0.9975414449449176,0,0,2
108,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6164421400991956,0.985097523559062,0.4765811318204916,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
109,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6181024073732202,1.108513779527559,0.5333072292119173,['HRAS'],0.9975414449449176,0,0,1
110,Alpha 6 Beta 4 signaling pathway WP244,0.6181024073732202,1.108513779527559,0.5333072292119173,['HRAS'],0.9975414449449176,0,0,1
111,Statin inhibition of cholesterol production WP430,0.6181024073732202,1.108513779527559,0.5333072292119173,['APOC1'],0.9975414449449176,0,0,1
112,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6181024073732202,1.108513779527559,0.5333072292119173,['HRAS'],0.9975414449449176,0,0,1
113,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6181024073732202,1.108513779527559,0.5333072292119173,['HRAS'],0.9975414449449176,0,0,1
114,Galanin receptor pathway WP4970,0.6181024073732202,1.108513779527559,0.5333072292119173,['POMC'],0.9975414449449176,0,0,1
115,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6181024073732202,1.108513779527559,0.5333072292119173,['FGF1'],0.9975414449449176,0,0,1
116,Histone Modifications WP2369,0.6181024073732202,1.108513779527559,0.5333072292119173,['SET'],0.9975414449449176,0,0,1
117,7q11.23 copy number variation syndrome WP4932,0.6216193696087318,0.9496753246753247,0.4515015940294063,"['ATP5MC2', 'ATP5F1E', 'ATP5MC1']",0.9975414449449176,0,0,3
118,Oncostatin M Signaling Pathway WP2374,0.6434660590931276,0.9330426658361881,0.41136544649230117,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
119,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.656878640493354,0.9851268591426072,0.41400546861290266,['HRAS'],0.9975414449449176,0,0,1
120,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.656878640493354,0.9851268591426072,0.41400546861290266,['RPS6'],0.9975414449449176,0,0,1
121,Interferon type I signaling pathways WP585,0.656878640493354,0.9851268591426072,0.41400546861290266,['RPS6'],0.9975414449449176,0,0,1
122,One-carbon metabolism and related pathways WP3940,0.656878640493354,0.9851268591426072,0.41400546861290266,['GPX4'],0.9975414449449176,0,0,1
123,Prolactin Signaling Pathway WP2037,0.6689645103482568,0.8861932938856015,0.35627121122717814,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
124,Amyotrophic lateral sclerosis (ALS) WP2447,0.691724636144072,0.8864173228346457,0.32670446346518556,['BAX'],0.9975414449449176,0,0,1
125,Canonical and non-canonical Notch signaling WP3845,0.691724636144072,0.8864173228346457,0.32670446346518556,['DLL3'],0.9975414449449176,0,0,1
126,Type II interferon signaling (IFNG) WP619,0.691724636144072,0.8864173228346457,0.32670446346518556,['HLA-B'],0.9975414449449176,0,0,1
127,Imatinib and Chronic Myeloid Leukemia WP3640,0.691724636144072,0.8864173228346457,0.32670446346518556,['SKP2'],0.9975414449449176,0,0,1
128,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.691724636144072,0.8864173228346457,0.32670446346518556,['HRAS'],0.9975414449449176,0,0,1
129,Notch Signaling WP268,0.691724636144072,0.8864173228346457,0.32670446346518556,['DLL3'],0.9975414449449176,0,0,1
130,p38 MAPK Signaling Pathway WP400,0.691724636144072,0.8864173228346457,0.32670446346518556,['HRAS'],0.9975414449449176,0,0,1
131,PDGF Pathway WP2526,0.691724636144072,0.8864173228346457,0.32670446346518556,['HRAS'],0.9975414449449176,0,0,1
132,Pregnane X receptor pathway WP2876,0.691724636144072,0.8864173228346457,0.32670446346518556,['PSMC5'],0.9975414449449176,0,0,1
133,Regulation of Microtubule Cytoskeleton WP2038,0.691724636144072,0.8864173228346457,0.32670446346518556,['PARD6A'],0.9975414449449176,0,0,1
134,Acute viral myocarditis WP4298,0.6929685070153887,0.8438057668826899,0.3094832530872508,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
135,Head and Neck Squamous Cell Carcinoma WP4674,0.6929685070153887,0.8438057668826899,0.3094832530872508,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
136,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6929685070153887,0.8438057668826899,0.3094832530872508,"['BAX', 'HRAS']",0.9975414449449176,0,0,2
137,Breast cancer pathway WP4262,0.6997093632773896,0.8431871758604432,0.30109389874495013,"['BAX', 'FGF1', 'HRAS', 'DLL3']",0.9975414449449176,0,0,4
138,Regulation of Actin Cytoskeleton WP51,0.7037347010815371,0.8302248023715415,0.29170267146545237,"['TMSB4X', 'BRK1', 'FGF1']",0.9975414449449176,0,0,3
139,DNA damage response WP707,0.7155184409591465,0.8052716514254976,0.26956299971197584,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
140,Melanoma WP4685,0.7155184409591465,0.8052716514254976,0.26956299971197584,"['BAX', 'HRAS']",0.9975414449449176,0,0,2
141,Hepatitis B infection WP4666,0.7219979226257177,0.8048868127919512,0.2621782101504322,"['CYCS', 'BAX', 'HRAS']",0.9975414449449176,0,0,3
142,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7230380454319153,0.8056549749463136,0.261268620528701,['RPS6'],0.9975414449449176,0,0,1
143,CAMKK2  Pathway WP4874,0.7230380454319153,0.8056549749463136,0.261268620528701,['FIS1'],0.9975414449449176,0,0,1
144,Vitamin D-sensitive calcium signaling in depression WP4698,0.7230380454319153,0.8056549749463136,0.261268620528701,['GPX4'],0.9975414449449176,0,0,1
145,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7230380454319153,0.8056549749463136,0.261268620528701,['CYCS'],0.9975414449449176,0,0,1
146,Apoptosis WP254,0.7366618703326749,0.7700883286167567,0.235359234242517,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
147,ESC Pluripotency Pathways WP3931,0.7366618703326749,0.7700883286167567,0.235359234242517,"['FGF1', 'HRAS']",0.9975414449449176,0,0,2
148,miRNA regulation of DNA damage response WP1530,0.7366618703326749,0.7700883286167567,0.235359234242517,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
149,Endothelin Pathways WP2197,0.7511763576000133,0.7383530183727034,0.21125374421670162,['RIIAD1'],0.9975414449449176,0,0,1
150,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7511763576000133,0.7383530183727034,0.21125374421670162,['CYCS'],0.9975414449449176,0,0,1
151,Integrated Cancer Pathway WP1971,0.7511763576000133,0.7383530183727034,0.21125374421670162,['BAX'],0.9975414449449176,0,0,1
152,Oxidative Damage WP3941,0.7511763576000133,0.7383530183727034,0.21125374421670162,['CYCS'],0.9975414449449176,0,0,1
153,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7511763576000133,0.7383530183727034,0.21125374421670162,['BAX'],0.9975414449449176,0,0,1
154,Allograft Rejection WP2328,0.7564516576941489,0.7378369493754109,0.20594257783698416,"['HLA-B', 'HLA-DRB1']",0.9975414449449176,0,0,2
155,Corticotropin-releasing hormone signaling pathway WP2355,0.7564516576941489,0.7378369493754109,0.20594257783698416,"['POMC', 'CRH']",0.9975414449449176,0,0,2
156,Retinoblastoma gene in cancer WP2446,0.7564516576941489,0.7378369493754109,0.20594257783698416,"['H2AFZ', 'SKP2']",0.9975414449449176,0,0,2
157,EGF/EGFR signaling pathway WP437,0.7715282658416681,0.7373188405797102,0.1912472136358296,"['NDUFA13', 'NEDD8', 'HRAS']",0.9975414449449176,0,0,3
158,TGF-beta Receptor Signaling WP560,0.7764609490485268,0.681405208964264,0.1724016018932502,['HRAS'],0.9975414449449176,0,0,1
159,Bladder cancer WP2828,0.7764609490485268,0.681405208964264,0.1724016018932502,['HRAS'],0.9975414449449176,0,0,1
160,DNA Replication WP466,0.7764609490485268,0.681405208964264,0.1724016018932502,['POLD4'],0.9975414449449176,0,0,1
161,Heart Development WP1591,0.7764609490485268,0.681405208964264,0.1724016018932502,['VEGFB'],0.9975414449449176,0,0,1
162,IL-5 signaling pathway WP127,0.7764609490485268,0.681405208964264,0.1724016018932502,['RPS6'],0.9975414449449176,0,0,1
163,Lung fibrosis WP3624,0.7764609490485268,0.681405208964264,0.1724016018932502,['FGF1'],0.9975414449449176,0,0,1
164,MECP2 and Associated Rett Syndrome WP3584,0.7764609490485268,0.681405208964264,0.1724016018932502,['RPS6'],0.9975414449449176,0,0,1
165,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7764609490485268,0.681405208964264,0.1724016018932502,['BAX'],0.9975414449449176,0,0,1
166,Small cell lung cancer WP4658,0.7921991853002133,0.6807768168714914,0.15858180069726768,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
167,DNA damage response (only ATM dependent) WP710,0.7921991853002133,0.6807768168714914,0.15858180069726768,"['BAX', 'HRAS']",0.9975414449449176,0,0,2
168,Aryl Hydrocarbon Receptor Pathway WP2873,0.7991807247194428,0.6325928008998876,0.14180717063257198,['BAX'],0.9975414449449176,0,0,1
169,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7991807247194428,0.6325928008998876,0.14180717063257198,['HRAS'],0.9975414449449176,0,0,1
170,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7991807247194428,0.6325928008998876,0.14180717063257198,['BAX'],0.9975414449449176,0,0,1
171,IL-3 signaling pathway WP286,0.7991807247194428,0.6325928008998876,0.14180717063257198,['HRAS'],0.9975414449449176,0,0,1
172,Alzheimer's disease WP2059,0.8082764071157273,0.6554167579808605,0.1395062375017282,"['ATP5MD', 'CYCS']",0.9975414449449176,0,0,2
173,Aryl Hydrocarbon Receptor Netpath WP2586,0.8195953934868886,0.5902887139107612,0.11743468305326385,['HRAS'],0.9975414449449176,0,0,1
174,Myometrial relaxation and contraction pathways WP289,0.8336655094452667,0.6795125666412795,0.12361898157009045,"['GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9975414449449176,0,0,4
175,Complement system WP2806,0.8371416288699156,0.6099435489355913,0.10842479288467285,"['RPS19', 'TXN']",0.9975414449449176,0,0,2
176,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8379384129767007,0.5532726377952756,0.09782450803234267,['RNF7'],0.9975414449449176,0,0,1
177,Notch Signaling Pathway Netpath WP61,0.8379384129767007,0.5532726377952756,0.09782450803234267,['DLL3'],0.9975414449449176,0,0,1
178,Pathways affected in adenoid cystic carcinoma WP3651,0.8379384129767007,0.5532726377952756,0.09782450803234267,['HRAS'],0.9975414449449176,0,0,1
179,PPAR signaling pathway WP3942,0.8379384129767007,0.5532726377952756,0.09782450803234267,['FABP6'],0.9975414449449176,0,0,1
180,Apoptosis Modulation and Signaling WP1772,0.85005019517969,0.5894806048652202,0.09576694720209641,"['CYCS', 'BAX']",0.9975414449449176,0,0,2
181,AGE/RAGE pathway WP2324,0.8544196386900759,0.5206113941639648,0.08190926172613032,['CYCS'],0.9975414449449176,0,0,1
182,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8544196386900759,0.5206113941639648,0.08190926172613032,['HRAS'],0.9975414449449176,0,0,1
183,Synaptic Vesicle Pathway WP2267,0.8544196386900759,0.5206113941639648,0.08190926172613032,['PARK7'],0.9975414449449176,0,0,1
184,ErbB signaling pathway WP673,0.8544196386900759,0.5206113941639648,0.08190926172613032,['HRAS'],0.9975414449449176,0,0,1
185,Glioblastoma signaling pathways WP2261,0.8544196386900759,0.5206113941639648,0.08190926172613032,['HRAS'],0.9975414449449176,0,0,1
186,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8593511212837489,0.6163250298740693,0.09342112102372183,"['SPARC', 'HRAS', 'DLL3']",0.9975414449449176,0,0,3
187,TGF-beta Signaling Pathway WP366,0.86202130418071,0.5703378507348731,0.08468107995143292,"['PARD6A', 'SUMO1']",0.9975414449449176,0,0,2
188,Differentiation Pathway WP2848,0.8692277057058364,0.4915791776027997,0.06889489850538165,['FGF1'],0.9975414449449176,0,0,1
189,Folate Metabolism WP176,0.8692277057058364,0.4915791776027997,0.06889489850538165,['GPX4'],0.9975414449449176,0,0,1
190,Integrin-mediated Cell Adhesion WP185,0.8692277057058364,0.4915791776027997,0.06889489850538165,['HRAS'],0.9975414449449176,0,0,1
191,Prostaglandin Synthesis and Regulation WP98,0.8692277057058364,0.4915791776027997,0.06889489850538165,['S100A6'],0.9975414449449176,0,0,1
192,Ebola Virus Pathway on Host WP4217,0.8731119436224583,0.5523915187376726,0.07495483525653579,"['HLA-B', 'HLA-DRB1']",0.9975414449449176,0,0,2
193,16p11.2 proximal deletion syndrome WP4949,0.8825321706526568,0.4656029838375466,0.05818176601397845,['SEZ6L2'],0.9975414449449176,0,0,1
194,G Protein Signaling Pathways WP35,0.8825321706526568,0.4656029838375466,0.05818176601397845,['HRAS'],0.9975414449449176,0,0,1
195,Senescence and Autophagy in Cancer WP615,0.8928700747058002,0.5196658545074835,0.05888552147577506,"['SPARC', 'HRAS']",0.9975414449449176,0,0,2
196,Osteoblast differentiation WP4787,0.8928700747058002,0.5196658545074835,0.05888552147577506,"['FGF1', 'DLL3']",0.9975414449449176,0,0,2
197,Circadian rhythm related genes WP3594,0.8943448301078506,0.5979526766235945,0.06676970526883869,"['CAVIN3', 'CRH', 'RPS27A', 'HCRTR1']",0.9975414449449176,0,0,4
198,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9052244916018141,0.42107236595425573,0.04192714774455333,['TMSB4X'],0.9975414449449176,0,0,1
199,Pancreatic adenocarcinoma pathway WP4263,0.9052244916018141,0.42107236595425573,0.04192714774455333,['BAX'],0.9975414449449176,0,0,1
200,Prader-Willi and Angelman Syndrome WP3998,0.9052244916018141,0.42107236595425573,0.04192714774455333,['POMC'],0.9975414449449176,0,0,1
201,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9097393263753186,0.4905763751917598,0.04640713923440288,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
202,Integrated breast cancer pathway WP1984,0.9097393263753186,0.4905763751917598,0.04640713923440288,"['BAX', 'FAU']",0.9975414449449176,0,0,2
203,Cell cycle WP179,0.9172101673480086,0.4772109387494003,0.04123992168325128,"['SKP2', 'ANAPC11']",0.9975414449449176,0,0,2
204,Gastrin signaling pathway WP4659,0.9172101673480086,0.4772109387494003,0.04123992168325128,"['RPS6', 'HRAS']",0.9975414449449176,0,0,2
205,T-cell receptor (TCR) signaling pathway WP69,0.9235399814272834,0.3842862033550154,0.030566580727948486,['HRAS'],0.9975414449449176,0,0,1
206,Exercise-induced Circadian Regulation WP410,0.9235399814272834,0.3842862033550154,0.030566580727948486,['SUMO1'],0.9975414449449176,0,0,1
207,Peptide GPCRs WP24,0.9235399814272834,0.3842862033550154,0.030566580727948486,['HCRTR1'],0.9975414449449176,0,0,1
208,B Cell Receptor Signaling Pathway WP23,0.9313265324576873,0.36819225721784776,0.02619515970221727,['HRAS'],0.9975414449449176,0,0,1
209,Metapathway biotransformation Phase I and II WP702,0.9362841832553427,0.4411242603550296,0.02904196002652517,"['GPX4', 'GSTO1']",0.9975414449449176,0,0,2
210,Neural Crest Differentiation WP2064,0.9383214908917554,0.35338582677165353,0.022497477453908128,['DLL3'],0.9975414449449176,0,0,1
211,Endoderm differentiation WP2853,0.9446051887060004,0.3397183525136281,0.019359947104104974,['NME1'],0.9975414449449176,0,0,1
212,NRF2 pathway WP2884,0.9466016472217106,0.41993049685357375,0.023044492855029092,"['FTH1', 'TXN']",0.9975414449449176,0,0,2
213,Spinal Cord Injury WP2431,0.9511440365891141,0.410072932434292,0.020540458816632086,"['BCAN', 'APEX1']",0.9975414449449176,0,0,2
214,Chemokine signaling pathway WP3929,0.9639658980234616,0.2941601049868766,0.01079548773517602,['HRAS'],0.9975414449449176,0,0,1
215,Mesodermal commitment pathway WP2857,0.9639658980234616,0.2941601049868766,0.01079548773517602,['RPL38'],0.9975414449449176,0,0,1
216,Hippo-Merlin Signaling Dysregulation WP4541,0.9709411342140327,0.27565206692913385,0.008128824098152626,['HRAS'],0.9975414449449176,0,0,1
217,Insulin Signaling WP481,0.9739056231482197,0.2672393223574326,0.007066041834500112,['HRAS'],0.9975414449449176,0,0,1
218,"GPCRs, Other WP117",0.9789595363060136,0.25185601799775026,0.0053557104062761565,['ADGRL2'],0.9975414449449176,0,0,1
219,Ciliopathies WP4803,0.9811072346897817,0.24480533683289588,0.004669297965615777,['CCDC28B'],0.9975414449449176,0,0,1
220,Focal Adhesion WP306,0.9820213895675092,0.32573599240265905,0.005909564012511024,"['VEGFB', 'HRAS']",0.9975414449449176,0,0,2
221,PI3K-Akt signaling pathway WP4172,0.9821767141992127,0.45164457535591557,0.00812239115416587,"['RPS6', 'VEGFB', 'COL9A3', 'FGF1', 'HRAS']",0.9975414449449176,0,0,5
222,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9841068527848534,0.4126266744321491,0.00661060843414543,"['RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9975414449449176,0,0,4
223,Vitamin D Receptor Pathway WP2877,0.9850648172275298,0.3139616793462947,0.004724443761607984,"['S100A6', 'HLA-DRB1']",0.9975414449449176,0,0,2
224,Nuclear Receptors Meta-Pathway WP2882,0.9900935530661492,0.3848982700467849,0.003831986467176407,"['PSMC5', 'FTH1', 'BAX', 'TXN']",0.9975414449449176,0,0,4
225,Ras signaling WP4223,0.9901020215736611,0.20955193100862393,0.0020844736325834807,['HRAS'],0.9975414449449176,0,0,1
226,MAPK Signaling Pathway WP382,0.9935907332428001,0.26994386284327115,0.00173571050309164,"['FGF1', 'HRAS']",0.9975414449449176,0,0,2
227,Calcium Regulation in the Cardiac Cell WP536,0.996635083807235,0.1688749242883101,0.0005692081741756798,['RGS6'],0.9975414449449176,0,0,1
228,"GPCRs, Class A Rhodopsin-like WP455",0.9975414449449176,0.23342537804076266,0.0005745957706195665,"['GPR35', 'HCRTR1']",0.9975414449449176,0,0,2
